These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients]. Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455 [TBL] [Abstract][Full Text] [Related]
4. Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement. Lin P; Jones D; Dorfman DM; Medeiros LJ Am J Surg Pathol; 2000 Nov; 24(11):1480-90. PubMed ID: 11075849 [TBL] [Abstract][Full Text] [Related]
5. Treatment of lymphoblastic lymphoma in adults. Hoelzer D; Gökbuget N Best Pract Res Clin Haematol; 2002 Dec; 15(4):713-28. PubMed ID: 12617872 [TBL] [Abstract][Full Text] [Related]
6. T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia: a separate entity? Hoelzer D; Gökbuget N Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S214-21. PubMed ID: 19778844 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas. Yeh KH; Cheng AL; Su IJ; Lin MT; Tien HF; Shen MC; Wang CH; Chen YC Anticancer Res; 1997; 17(3C):2269-72. PubMed ID: 9216700 [TBL] [Abstract][Full Text] [Related]
9. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients]. Qin Y; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang JL; Yang S; Zhang CG; Dong M; Zhou LQ; Wang JW; Feng FY; Sun Y Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):469-73. PubMed ID: 19950562 [TBL] [Abstract][Full Text] [Related]
10. Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment. Bassan R; Maino E; Cortelazzo S Eur J Haematol; 2016 May; 96(5):447-60. PubMed ID: 26679753 [TBL] [Abstract][Full Text] [Related]
11. B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology. Soslow RA; Baergen RN; Warnke RA Cancer; 1999 Jun; 85(12):2648-54. PubMed ID: 10375114 [TBL] [Abstract][Full Text] [Related]
14. [Clinical outcome of autologous stem cell transplantation as first-line treatment in 30 patients with high risk lymphoblastic lymphoma]. Huang W; Zou D; Sui W; Wang T; Fu M; Li Z; Xu Y; Zhao Y; Feng S; Han M; Qiu L Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):332-6. PubMed ID: 24759023 [TBL] [Abstract][Full Text] [Related]
15. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group. Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688 [TBL] [Abstract][Full Text] [Related]
16. Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial. Ribera JM; Oriol A; Morgades M; Montesinos P; Sarrà J; González-Campos J; Brunet S; Tormo M; Fernández-Abellán P; Guàrdia R; Bernal MT; Esteve J; Barba P; Moreno MJ; Bermúdez A; Cladera A; Escoda L; García-Boyero R; Del Potro E; Bergua J; Amigo ML; Grande C; Rabuñal MJ; Hernández-Rivas JM; Feliu E J Clin Oncol; 2014 May; 32(15):1595-604. PubMed ID: 24752047 [TBL] [Abstract][Full Text] [Related]
17. The prognostic role of E2A-PBX1 expression detected by real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) in B cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation. Hong Y; Zhao X; Qin Y; Zhou S; Chang Y; Wang Y; Zhang X; Xu L; Huang X Ann Hematol; 2018 Sep; 97(9):1547-1554. PubMed ID: 29705861 [TBL] [Abstract][Full Text] [Related]
18. Distinct clinical features of infectious complications in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis in the Nagasaki transplant group. Itonaga H; Taguchi J; Fukushima T; Tsushima H; Sato S; Ando K; Sawayama Y; Matsuo E; Yamasaki R; Onimaru Y; Imanishi D; Imaizumi Y; Yoshida S; Hata T; Moriuchi Y; Honda S; Miyazaki Y Biol Blood Marrow Transplant; 2013 Apr; 19(4):607-15. PubMed ID: 23333533 [TBL] [Abstract][Full Text] [Related]
19. Clinical features and treatment outcomes of adult B- and T-lymphoblastic lymphoma: results of multicentre analysis in Korea. Chang MH; Kim SJ; Kim K; Oh SY; Lee DH; Huh J; Ko YH; Choi CW; Yang DH; Won JH; Kim WS; Suh C Leuk Lymphoma; 2009 Jul; 50(7):1119-25. PubMed ID: 19557632 [TBL] [Abstract][Full Text] [Related]
20. Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation. Seriu T; Yokota S; Nakao M; Misawa S; Takaue Y; Koizumi S; Kawai S; Fujimoto T Leukemia; 1995 Apr; 9(4):615-23. PubMed ID: 7723394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]